全身MRI在跨年龄炎症性关节炎肌肉骨骼炎症检测与治疗反应评估中的作用:一项系统综述
本系统综述检索PubMed、MEDLINE和Cochrane数据库至2021年4月11日,纳入19项全文研究共540例参与者,评估全身MRI(WBMRI)结局与疾病活动度指标及治疗反应检测的关系。WBMRI检测的滑膜炎频率高于临床检查,附着点炎检出少于临床检查;生物制剂治疗后部分研究WBMRI炎症评分下降,部分结果不明确。总体而言WBMRI评估疾病活动度和治疗反应的能力尚可,需进一步研究证实。
要点
- WBMRI检测的滑膜炎频率在银屑病关节炎、脊柱关节炎和类风湿关节炎中均高于临床检查。
- 8项研究中有5项显示WBMRI检出的附着点炎少于临床检查。
- 生物制剂治疗后,3项脊柱关节炎和2项类风湿关节炎研究显示WBMRI炎症评分下降,3项研究结果不明确。
核心结论
- WBMRI评估炎症性关节炎疾病活动度和治疗反应的能力总体尚可。
- 需进一步研究以证实WBMRI发现与炎症性关节炎结局的关系,并探究亚临床炎症的临床价值。
研究设计与样本
- 系统综述,由两名评价者独立系统检索PubMed、MEDLINE和Cochrane数据库自建库至2021年4月11日的全文或摘要发表的人类研究。
- 纳入19项全文研究:2项干预性研究、7项回顾性观察性研究和10项前瞻性观察性研究,共540例参与者(脊柱关节炎38.7%、类风湿关节炎24.8%、幼年特发性关节炎17.8%、银屑病关节炎11.5%、健康对照5.9%、未分类炎症性关节炎1.3%)。
- 另单独报告了6篇会议论文摘要。
主要发现
- 银屑病关节炎和脊柱关节炎中5项研究、类风湿关节炎中4项研究测量了WBMRI检测与临床检测的滑膜炎频率,所有研究均发现WBMRI检测的滑膜炎更频繁。
- 8项研究中有5项显示WBMRI检出的附着点炎少于临床检查。
- 生物制剂治疗后,3项脊柱关节炎研究和2项类风湿关节炎研究中WBMRI炎症评分下降,另有3项研究结果不明确。
局限性
- 需进一步研究以证实WBMRI发现与炎症性关节炎结局的关系,并探究亚临床炎症的临床价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the relation between whole-body MRI (WBMRI) outcomes and disease activity measures, including clinical examination, composite scores, and other imaging outcomes, and the ability of WBMRI to detect treatment response in patients with inflammatory arthritis (IA) across age. METHODS: Human studies published as full text or abstract in the PubMed and MEDLINE and Cochrane databases from inception to 11th April 2021 were systematically and independently searched by two reviewers. Studies including patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), spondyloarthritis (SpA), juvenile idiopathic arthritis (JIA) or unclassified inflammatory arthritis (UA) who underwent WBMRI and which reported on disease outcomes were included. RESULTS: Nineteen full-text studies were eligible for inclusion: 2 interventional, 7 retrospective and 10 prospective observational studies, comprising 540 participants (SpA 38.7%, RA 24.8%, JIA 17.8%, PsA 11.5%, healthy controls 5.9%, UA 1.3%). Abstracts of 6 conference papers were reported separately. Five studies in PsA and SpA and 4 in RA measured the frequency of WBMRI-detected and clinically-detected synovitis, and all found the former to be more frequent. Less enthesitis was detected by WBMRI than clinical examination in 5/8 studies. After biologic treatment, the WBMRI inflammation scores declined in 3 studies in SpA and 2 in RA, whilst in 3 studies the results were equivocal. CONCLUSION: The ability of WBMRI to assess disease activity and treatment response in IA was adequate overall. Further studies are needed to corroborate WBMRI findings with IA outcomes and investigate the clinical value of subclinical inflammation.
引用
- Choida V, Madenidou AV, Sen D, et al. The role of whole-body MRI in musculoskeletal inflammation detection and treatment response evaluation in inflammatory arthritis across age: A systematic review. Semin Arthritis Rheum. 2022. PMID: 35038643. doi:10.1016/j.semarthrit.2022.151953
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。